<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="26907">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02102815</url>
  </required_header>
  <id_info>
    <org_study_id>OrthoTU06</org_study_id>
    <nct_id>NCT02102815</nct_id>
  </id_info>
  <brief_title>Efficacy of Preoperative Intravenous Dexamethasone in Primary Total Knee Arthroplasty</brief_title>
  <acronym>TKA</acronym>
  <official_title>Efficacy of Preoperative Intravenous Dexamethasone in Controlling Postoperative Pain After Primary Total Knee Arthroplasty: A Randomized Double-blinded Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thammasat University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thammasat University</source>
  <oversight_info>
    <authority>Thailand: Ethical Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine efficacy of preoperative IV dexamethasone for postoperative pain control after
      TKA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preoperative intravenous over 0.1 mg/kg of dexamethasone could be reduced pain after primary
      TKA.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>post-operative pain</measure>
    <time_frame>48 hours</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>measured with VAS for pain, drugs for relief pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional knee score</measure>
    <time_frame>3 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured with WOMAC, KSS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative nausea and vomiting</measure>
    <time_frame>48 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured with amount of nausea/vomiting and drugs requiring for fixed its.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complication of preoperative dexamethasone</measure>
    <time_frame>2 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>measured with wound complication, blood sugar level, WBC count</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Knee range of motion</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>measuring range of motion with goniometer</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Dexamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Preoperative dexamethasone 8 mg (if body wight &lt; 80 kilograms) or 12 mg (if body weight &gt;/= 80 kilograms) mixed with NSS to 50 mL IV slowly push over 5 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Preoperative intravenous normal saline 50 mL slowly push over 5 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Dexamethasone 8-12 mg mixed with NSS up to 50 mL IV slowly push over 5 minutes</description>
    <arm_group_label>Dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>NSS 50 mL IV slowly push over 5 minutes</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Osteoarthritis of the knee who undergoing unilateral primary total knee arthroplasty

          -  50-85 years old

          -  ASA class 1-3

        Exclusion Criteria:

          -  Unable to perform spinal anaesthesia

          -  History of drug allergies: steroids

          -  Renal impairment (CrCl &lt;30 mL/min)

          -  Liver impairment

          -  Cognitive function disorders

          -  Poor controlled DM (HA1C &gt; 7.5)

          -  Morning DTX at operative day &gt; 180 mg%

          -  Received corticosteroids within 3 months before surgery
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Supakit Kanitnate, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopaedics department, Thammasat University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Supakit Kanitnate, M.D.</last_name>
    <phone>6629269775</phone>
    <email>naypeng@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Orthopaedic department, Faculty of medicine, Thammasat university</name>
      <address>
        <city>Klongluang</city>
        <state>Pathumthani</state>
        <zip>066</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>supakit kanitnate</last_name>
      <phone>6629269775</phone>
      <email>naypeng@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 4, 2014</lastchanged_date>
  <firstreceived_date>March 31, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Thammasat University</investigator_affiliation>
    <investigator_full_name>Supakit Kanitnate</investigator_full_name>
    <investigator_title>Orthopaedics department</investigator_title>
  </responsible_party>
  <keyword>total knee arthroplasty</keyword>
  <keyword>pain control</keyword>
  <keyword>dexamethasone</keyword>
  <keyword>steroids</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexamethasone 21-phosphate</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
